Exact Mass: 592.4339

Exact Mass Matches: 592.4339

Found 79 metabolites which its exact mass value is equals to given mass value 592.4339, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4339)

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4339)

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4339)

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4339)

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4339)

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4339)

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4339)

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4339)

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0)

(2S)-2-hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C35H60O7 (592.4339)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4339)

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4339)

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4339)

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4339)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Aromin

C35H60O7 (592.4339)

Montanacin E

C35H60O7 (592.4339)

Ikshusterol 3-O-glucoside

(2R,3R,4S,5S,6R)-2-[[(3S,7S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-7-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4339)

(24R)-24-ethyl-6beta-[(beta-D-glucopyranosyl)oxy]-5beta-cholest-9-ene-12alpha-ol|opuntisteroside

C35H60O7 (592.4339)

2-[hydroxy-[2-nonanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[2-heptanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[hydroxy-[3-octoxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[2-butanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[hydroxy-[3-nonoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[hydroxy-[2-octanoyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[2-acetyloxy-3-[(Z)-henicos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[3-decoxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[2-decanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

2-[[3-[(Z)-heptadec-9-enoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4342)

ST 29:0;O;GlcA

C35H60O7 (592.4339)

ST 29:1;O2;Hex

C35H60O7 (592.4339)

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5s)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5s)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4339)

(5s)-3-{[(2s,6r)-6-[(7s)-7-hydroxy-7-[(2s,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

2-{[1-(7-hydroxy-5-isopropylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4339)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,4r,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,4r,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4339)

(5r)-3-{[(2s,5s)-5-[(8s)-8-hydroxy-8-[(2s,5s)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(5s)-3-{[(2r,6s)-6-[(7r)-7-hydroxy-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

2-{[1-(5-ethyl-6-methylheptan-2-yl)-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4339)

(5r)-3-{[(2s,6r)-6-[(7r)-7-hydroxy-7-[(2r,5s)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(5s)-3-{[(2r,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(5s)-3-{[(2r,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1s)-1-hydroxytridecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

(5s)-3-{[(2s,6r)-6-[(7r)-7-hydroxy-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

3-[(5-{8-hydroxy-8-[5-(1-hydroxytridecyl)oxolan-2-yl]-2-oxooctyl}oxolan-2-yl)methyl]-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)

3-[(6-{7-hydroxy-7-[5-(1-hydroxytridecyl)oxolan-2-yl]-2-oxoheptyl}oxan-2-yl)methyl]-5-methyl-5h-furan-2-one

C35H60O7 (592.4339)